Similar to lupus-prone B6.TC/Rab4AQ72L mice, flow cytometry of SLE and control participants, who had been matched for age and gender in the context of a clinical trial15, unveiled an expansion of CD98+ DN T cells in SLE patients (Fig. 9A, B). This evidence concerns the gene SLC7A5 and systemic lupus erythematosus.